[Hemolytic-uremic syndrome during oral contraception]

Area of Science:

• Nephrology
• Hematology
• Endocrinology

Background:

• Oral contraceptives are widely used for birth control.
• Hemolytic uremic syndrome (HUS) is a serious condition characterized by red blood cell destruction, low platelet count, and kidney failure.
• Thrombotic microangiopathies are a group of disorders characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage.

Observation:

• A 41-year-old woman developed HUS after 18 years of oral contraceptive use.
• Renal biopsy confirmed advanced thrombotic microangiopathy.
• Standard etiological work-up was negative, but radioimmunoassay detected positive steroidal anti-hormone antibodies.

Findings:

• Treatment involved hemodialysis, fresh plasma, anticoagulation (heparin), dipyridamole, and antihypertensives.
• Eight months post-treatment, creatinine clearance was 45 ml/min with persistent ischemic renal lesions.
• The case highlights a rare association between oral contraceptives and HUS, with a severe prognosis despite treatment.

Implications:

• The study suggests a potential link between oral contraceptives and HUS, possibly mediated by steroidal anti-hormone antibodies.
• Early detection of at-risk patients and evaluation of antibody testing are crucial for prevention.
• This case underscores the importance of considering HUS in patients using oral contraceptives presenting with relevant symptoms.